These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12039843)

  • 1. Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa.
    Grouzmann E; Monod M; Landis B; Wilk S; Brakch N; Nicoucar K; Giger R; Malis D; Szalay-Quinodoz I; Cavadas C; Morel DR; Lacroix JS
    FASEB J; 2002 Jul; 16(9):1132-4. PubMed ID: 12039843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of dipeptidylpeptidase IV activity in human bronchial inflammation and in bronchoconstriction evaluated in anesthetized rabbits.
    Landis BN; Grouzmann E; Monod M; Busso N; Petak F; Spiliopoulos A; Robert JH; Szalay-Quinodoz I; Morel DR; Lacroix JS
    Respiration; 2008; 75(1):89-97. PubMed ID: 17637510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the enzyme peptidyl peptidase IV in nasal mucosa].
    Giger R; Nicoucar K; Kurt AM; Grouzman E; Lacroix JS
    Schweiz Med Wochenschr; 2000; Suppl 125():99S-101S. PubMed ID: 11141955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory neuropeptides and nitric oxide in nasal vascular regulation.
    Rinder J
    Acta Physiol Scand Suppl; 1996; 632():1-45. PubMed ID: 8800374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory and motor reflex control of nasal mucosal blood flow and secretion; clinical implications in non-allergic nasal hyperreactivity.
    Stjärne P
    Acta Physiol Scand Suppl; 1991; 600():1-64. PubMed ID: 1891972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps.
    Liu Z; Lu X; Wang H; You XJ; Gao QX; Cui YH
    Allergy; 2007 Sep; 62(9):999-1006. PubMed ID: 17578498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of substance P on human skin and nasal airways.
    Miadonna A; Tedeschi A; Leggieri E; Lorini M; Qualizza R; Froldi M; Zanussi C
    Ann Allergy; 1988 Sep; 61(3):220-3. PubMed ID: 2458061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenic plasma extravasation in the rat nasal mucosa is potentiated by peptidase inhibitors.
    Petersson G; Bacci E; McDonald DM; Nadel JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):509-14. PubMed ID: 8423549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective and subjective evaluation of endoscopic nasal surgery outcomes.
    Giger R; Landis BN; Zheng C; Malis DD; Ricchetti A; Kurt AM; Morel DR; Lacroix JS
    Am J Rhinol; 2003; 17(6):327-33. PubMed ID: 14750607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vascular endothelial growth factor on nasal vascular permeability.
    Matsune S; Ohori J; Yoshifuku K; Kurono Y
    Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of surfactant protein A in chronic rhinosinusitis.
    Lee HM; Kang HJ; Woo JS; Chae SW; Lee SH; Hwang SJ
    Laryngoscope; 2006 Feb; 116(2):328-30. PubMed ID: 16467728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and children featuring nasal polyps.
    Hu KH; Lee FP; Cheng YJ; Huang HM
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):23-8. PubMed ID: 16987554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.
    Corrigan C; Mallett K; Ying S; Roberts D; Parikh A; Scadding G; Lee T
    J Allergy Clin Immunol; 2005 Feb; 115(2):316-22. PubMed ID: 15696087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurogenic inflammation and chronic rhinosinusitis].
    Lacroix JS; Ricchetti Coignard A
    Rev Med Suisse; 2005 Oct; 1(37):2392-5. PubMed ID: 16300282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunocytochemical study on relations between mast cell and peptidergic terminals in nasal mucosa of chronic rhinitis patients.
    Zhao C; Tao Z; Xiao J; Zhao S; Qiao J
    Chin Med J (Engl); 1995 Aug; 108(8):606-9. PubMed ID: 7587493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model.
    Ooi EH; Wormald PJ; Carney AS; James CL; Tan LW
    Laryngoscope; 2007 Jan; 117(1):51-7. PubMed ID: 17202930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of monoamine oxidase in nasal mucosa in patients with chronic rhinosinusitis].
    Bykova VP
    Vestn Otorinolaringol; 1971; 33(3):83-6. PubMed ID: 4938303
    [No Abstract]   [Full Text] [Related]  

  • 19. Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
    Grouzmann E; Bigliardi P; Appenzeller M; Pannatier A; Buclin T
    Biol Chem; 2011 Mar; 392(3):217-21. PubMed ID: 21194357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in nasal volume flow following local administration of neuropeptide substance P and capsaicin].
    Wolf G; Loidolt D; Saria A; Gamse R
    Laryngol Rhinol Otol (Stuttg); 1987 Aug; 66(8):412-5. PubMed ID: 2444849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.